drugset / Trial / NCT05123170
Dexmedetomidine in IVRA
RandomizedParallel-groupDouble-blindDiagnostic
Summary
A prospective randomized controlled double-blinded study will be conducted on 90 patients assigned randomly into three equal groups,
Timeline
- Start
- 2020-02-28
- Primary completion
- 2021-03-25
- Completion
- 2021-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.25 ug/kg | Intravenous |
| Comparator | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | Intravenous |
| Comparator | Lidocaine | Other / unclassified | 3 mg/kg | Intravenous |
Indications
No indication recorded.